Literature DB >> 19279360

Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.

Hossein Mortazavi1, Majid Shahdi, Ali Akbar Amirzargar, Zahra S Naraghi, Mahin Valikhani, Maryam Daneshpazhooh, Amir Vasheghani-Farahani, Mojtaba Sedaghat, Cheyda Chams-Davatchi.   

Abstract

Anti-desmoglein 3 and 1 autoantibodies are involved in the pathogenesis of pemphigus diseases. Our objective was to assess the value of ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris. Based on clinical presentation and histopathologic confirmation for the diagnosis of the pemphigus, 38 patients took part in the study. Sera of the patients were tested by desmoglein 1 and desmoglein 3 ELISA. Also, direct immunofluorescence was performed for all patients which revealed positive results in 36 patients (94.7%). ELISA was positive in 37 of 38 pemphigus patients (Sensitivity: 97.3%). The relationship between desmoglein 1 index values and skin severity was statistically significant (p<0.05). Desmoglein 3 index values increased with oral severity although this was not statistically significant. Iranian patients similar to Indian patients had higher positive anti-desmoglein 1 autoantibodies. Desmoglein-ELISA test is appropriate in the diagnosis of pemphigus. Desmoglein 1 index value is statistically correlated with the severity of pemphigus vulgaris.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279360     DOI: 08.01/ijaai.5356

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  9 in total

1.  Analysis of the Specificity of Auto-Reactive Antibodies to Individual Fragments of the Extracellular Domain of Desmoglein 3 in Patients with Pemphigus Vulgaris.

Authors:  A A Kubanov; D G Deryabin; M V Shpilevaya; A E Karamova; A A Nikonorov; E N Larina; T K Aliev; D A Dolgikh; T V Bobik; I V Smirnov; A G Gabibov; M P Kirpichnikov
Journal:  Bull Exp Biol Med       Date:  2021-09-20       Impact factor: 0.804

2.  Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity.

Authors:  Zahra Delavarian; Pouran Layegh; Atessa Pakfetrat; Nazila Zarghi; Mahboubeh Khorashadizadeh; Ala Ghazi
Journal:  J Clin Exp Dent       Date:  2020-05-01

3.  Salivary desmoglein enzyme-linked immunosorbent assay for diagnosis of pemphigus vulgaris: a noninvasive alternative test to serum assessment.

Authors:  Hossein Mortazavi; Alireza Khatami; Zahra Seyedin; Iman Vasheghani Farahani; Maryam Daneshpazhooh
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

4.  Comparison of Immunofluorescence and Desmoglein Enzyme-linked Immunosorbent Assay in the Diagnosis of Pemphigus: A Prospective, Cross-sectional Study in a Tertiary Care Hospital.

Authors:  Deepthi Ravi; S Smitha Prabhu; Raghavendra Rao; C Balachandran; Indira Bairy
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

Review 5.  New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature.

Authors:  Rachel R Xuan; Anes Yang; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-02-03

6.  Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant.

Authors:  Giulio Fortuna; Elena Calabria; Massimo Aria; Amerigo Giudice; Michele Davide Mignogna
Journal:  Biomolecules       Date:  2021-11-04

7.  Pathological findings of pemphigus vulgaris showing giant cobblestone-like conjunctival papillae.

Authors:  Hiroyuki Namba; Mari Narumi; Akira Sugano; Ichidai Murata; Tamio Suzuki; Mitsunori Yamakawa; Hidetoshi Yamashita
Journal:  Case Rep Ophthalmol       Date:  2013-09-19

8.  Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity.

Authors:  Naiyu Lin; Qingxiu Liu; Menglei Wang; Qian Wang; Kang Zeng
Journal:  PeerJ       Date:  2018-08-03       Impact factor: 2.984

9.  Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab.

Authors:  Hoorieh Alaeen; Roja Toosi; Hamidreza Mahmoudi; Kamran Balighi; Soheil Tavakolpour; Amir Teimoupour; Maryam Daneshpazhooh
Journal:  Int J Womens Dermatol       Date:  2019-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.